|
|
|
Price To Cash flow Ratio for Medical Laboratories Industry
Valuation Information & Trends 
Price
To Earnings Ratio |
3 Q |
2 Q |
1 Q |
4 Q |
3 Q |
| |
2024 |
2024 |
2024 |
2023 |
2023 |
| PE (TTM) Ratio |
current 148.41 |
32.72 |
34.29 |
32.75 |
32.05 |
| Cumulative Net Income TTM Q / Q Growth |
-2.63 % |
1.44 % |
-0.22 % |
1.53 % |
-4.42 % |
| Stock performance |
to date  -7.07 % |
 7.35 % |
1.75 % |
12.24 % |
-13.47 % |
Note, third quarter 2024 Numbers include only companies who have reported third quarter 2024 earnings results. Numbers change as more businesses report financial results. See the full List.
|
| Price to earnings ratio Comment |
Price to earnings ratio for the Medical Laboratories Industry
Despite share price contraction of -7.07 %, from beginning of the third quarter 2024 Medical Laboratories Industry's current Price to earnings ratio has increased due to the sequential decline in net income for the trailing twelve month period, by -2.63 %, to Pe of 148.48, from the average Price to earnings ratio in the second quarter 2024 of 32.72.
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
